The future of national cancer institutes is promising, with ongoing advancements in immunotherapy, genetic research, and personalized medicine. These institutes are expected to continue their pivotal role in revolutionizing cancer treatment and improving patient outcomes. The integration of artificial intelligence and big data analytics also holds significant potential for enhancing research and clinical care.
